Ledger.Open graph →

SEC Form D · Amendment · filed June 12, 2023

SightStream Biotherapeutics, Inc

Offering

$3.5M

Sold

$3.1M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

MEDFIELD, MA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

David Neafus · Medfield, MAExec Jiagang Zhao · Medfield, MADirector Reza Dana · Medfield, MADirector Jason Werner · Medfield, MAExec · Director George Mulhern · Boise, IDExec Rick Farnell · Boise, IDDirector Nick Efstratis · Boise, IDExec · Director Brad Osborne · Brentwood, TNDirector Robert J. Short · Polson, MTDirector Chris Popp · New York, NYExec Mike Tobin · New York, NYDirector Jean-Bastien Auger · New York, NYExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗